Vir Biotechnology, Inc.

Amalio Telenti

Davide Corti

Gyorgy Pal Snell

Martina Beltramello

Elisabetta Cameroni

Florian A Lempp

Katja Fink

Dora Pinto

The instant disclosure provides antibodies and antigen-binding fragments thereof that can bind to a SARS-CoV-2 antigen and, in certain embodiments, are capable of neutralizing a SARS-CoV-2 infection. Also provided are polynucleotides that encode an antibody or antigen-binding fragment, vectors and host cells that comprise a polynucleotide, pharmaceutical compositions, and methods of using the presently disclosed antibodies, antigen-binding fragments, polynucleotides, vectors, host cells, and compositions to treat or diagnose a SARS-CoV-2 infection.

Antibodies against SARS-CoV-2 and methods of using the same

Growing community of inventors

San Francisco, CA, United States of America

Amalio Telenti